Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03985371 · ClinicalTrials.gov registry record · Early Phase 1
A Pilot Study to Assess the Preliminary Efficacy of EDTA Eye Drops on Band Keratopathy
A Early Phase 1 study of Corneal Dystrophy, Band-Shaped, sponsored by University of Rochester.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT03985371 is a Early Phase 1 study of Corneal Dystrophy, Band-Shaped that has completed, run by University of Rochester. The registered enrollment target is 3 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03985371, a Early Phase 1 study of Corneal Dystrophy, Band-Shaped, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to collect preliminary efficacy and safety data on the use of EDTA EYE Drops (EED) on subjects during an episode of band keratopathy (BK).
Conditions Studied
Interventions
- DRUG EDTA Eye Drops
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-06-29 |
| Est. Completion | 2021-09-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03985371
The ClinicalTrials.gov registry entry for NCT03985371 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Corneal Dystrophy, Band-Shaped appearing as the primary indexed condition, and to 1 intervention - of which EDTA Eye Drops is the first listed.
NCT03985371 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03985371 about?
NCT03985371 is a clinical study titled "A Pilot Study to Assess the Preliminary Efficacy of EDTA Eye Drops on Band Keratopathy". The objective of this study is to collect preliminary efficacy and safety data on the use of EDTA EYE Drops (EED) on subjects during an episode of band keratopathy (BK).
What is the current status of trial NCT03985371?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2020-06-29. Estimated completion is 2021-09-30.
What conditions does trial NCT03985371 study?
This clinical trial studies the following conditions: Corneal Dystrophy, Band-Shaped.
What interventions are being tested in trial NCT03985371?
The interventions under investigation include: EDTA Eye Drops (DRUG).
Who is sponsoring clinical trial NCT03985371?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03985371 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.